Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.
暂无分享,去创建一个
J. Lundgren | J. Neaton | B. Grund | M. Law | I. Williams | E. Ekong | L. Vandekerckhove | M. Schechter | T. Benfield | J. Molina | M. Wiselka | F. Gordin | A. Skoutelis | M. Losso | D. Munroe | N. Mwelase